Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRUJ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $134,214
Award facts
- Contract value 100% obligated
- $134,213.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $134,213.70 to AmerisourceBergen Drug Corp for DUPIXENT (dupilumab) 300 mg/2 mL pen injectors on September 4, 2025, with a completion date of September 5, 2025. This competitive award uses firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be supplied from AmerisourceBergen's headquarters location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured.
This delivery order supports the Defense Health Agency's medical supply chain requirements for DUPIXENT, a biologic immunosuppressant commonly prescribed for moderate-to-severe atopic dermatitis, eczema, and certain allergic conditions affecting military personnel and beneficiaries. AmerisourceBergen serves as a critical pharmaceutical distributor for federal healthcare systems through its comprehensive IDC vehicle, which enables the company to supply brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic categories to support military healthcare programs globally. The company's proven capacity to meet federal procurement standards through open competition and its extensive portfolio of pharmaceutical deliveries make it well-positioned to fulfill this specialized medical supply requirement.
Quick answers
Who was awarded contract SPE2DB25FRUJ9?
SPE2DB25FRUJ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FRUJ9 worth?
The government has obligated $134,214 on SPE2DB25FRUJ9.
Is contract SPE2DB25FRUJ9 an order under another contract?
Yes. SPE2DB25FRUJ9 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRUJ9 competed?
The extent of competition for SPE2DB25FRUJ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award